Atlas FDA

Freestyle Libre 14 day Flash Glucose Monitoring System

FDA premarket approval P160030/S048 · decided 2022-01-19

Approval details

PMA number
P160030
Supplement
S048
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Postapproval Study Protocol
Trade name
Freestyle Libre 14 day Flash Glucose Monitoring System
Generic name
Sensor, glucose, invasive, non-adjunctive, factory-calibrated, user-initiated
Applicant
Abbott Diabetes Care, Inc.
Date received
2021-12-20
Decision date
2022-01-19
Days to decision
30 days
Decision code
APPR
Product code
PZE
Advisory committee
Clinical Chemistry
Expedited review
No
Location
Alameda, CA
Statement
Approval of the revised protocol for the post-approval study

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
FreeStyle Libre 3 Continuous Glucose Monitoring System; FreeStyle Libre 2 Flash Glucose Monitoring System (K233537)Abbott Diabetes Care, Inc.2024-04-23
FreeStyle Libre 3 Continuous Glucose Monitoring System; FreeStyle Libre 2 Flash Glucose Monitoring System (K223435)Abbott Diabetes Care, Inc.2023-04-13
FreeStyle Libre 2 Flash Glucose Monitoring System; Freestyle Libre 3 Continuous Glucose Monitoring System (K222447)Abbott Diabetes Care, Inc.2023-03-03
FreeStyle Libre 2 System, FreeStyle Libre 3 System (K223537)Abbott Diabetes Care, Inc.2023-02-21
FreeStyle Libre 3 Continuous Glucose Monitoring System (K212132)Abbott Diabetes Care, Inc.2022-05-26
FreeStyle Libre 3 Continuous Glucose Monitoring System (K213996)Abbott Diabetes Care, Inc.2022-05-26
FreeStyle Libre 2 Flash Glucose Monitoring System (with FreeStyle Libre 2 App) (K210943)Abbott Diabetes Care, Inc.2021-11-22
FreeStyle Libre 2 Flash Glucose Monitoring System (K211102)Abbott Diabetes Care, Inc.2021-08-11